Fundraising FoxVIB
FoundationGhent · Seed–Series A · 3 people tracked
Find your way into VIB
Sign up to see every warm intro you have to VIB
- Paths you didn't know you had: your email and LinkedIn already hold routes to the VIB team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
VIB is a Flemish life sciences research institute focused on conducting groundbreaking biomolecular research for scientific and societal benefit. It allocates most of its budget to research, with a significant share dedicated to technology transfer aimed at converting research into viable business ventures for consumer and patient benefit. Its research spans humans, plants, and microorganisms, studying normal and pathological cellular and organismal processes. Researchers are embedded within departments across four Flemish universities to foster collaboration. As a member of EU-LIFE, VIB emphasizes excellence in life sciences, dissemination of scientific knowledge to the public, and contribution to economic development.
Source: firm website, verified Sep 27, 2026.
Team · 3 people
from the firm's website
Founder mafia
5 people who came through VIB went on to found or lead other companies.
What they invest in
from 8 of 8 portfolio companiesBiotech ×7Healthtech ×5AgTech ×3AI & Machine Learning ×2Deep Tech ×2Medical Devices ×2Digital Health ×1Enterprise Software ×1
HQs:Belgium×6
Investments · 8 tracked
founders shown can be your intro pathBy year:2026 · 12023 · 12020 · 13 dated
ExeVir develops multi-specific VHH antibody therapies to treat infectious diseases, immunological conditions, and oncology, with a focus on immunocompromised populations.
BiotechDeep TechDigital HealthHealthtechMedical DevicesGhent, BE
Xavier Saelens(Scientific Founder)Nico Callewaert(Scientific Founder)inMike Garrett(Chief Executive Officer)
Co-investorsV-Bio VenturesSambrinvestUCB VenturesFund+VIVES Partners
Montis Biosciences develops anti-C1q antibodies that target both the complement and myeloid axes to treat neuroinflammatory, autoimmune, neurodegenerative and ophthalmic diseases, with a lead program in Guillain-Barré syndrome and a second CD93 program in lung squamous cell carcinoma.
BiotechHealthtechLeuven, BE
Federico Grossi(Clinical Advisor & Acting CMO)
Co-investorsDroia VenturesPfizer VenturesPfizer Venture InvestmentsPolaris Partners
Montis Biosciences is a biotechnology company developing anti-C1q antibodies that target both the complement and myeloid axes to treat neuroinflammatory, autoimmune, neurodegenerative and ophthalmic diseases, with a lead program in Guillain-Barré syndrome.
BiotechHealthtechLeuven, BE
Federico Grossi(Clinical Advisor & Acting CMO)
Co-investorsDroia VenturesPfizer VenturesPfizer Venture Investments
MRM Health develops microbiome-based therapeutics using a precision-engineered platform called CORAL®, which designs and manufactures live bacterial consortia to treat diseases caused by microbiome dysbiosis.
BiotechHealthtechMedical DevicesGhent, BE
Protealis breeds legume crops such as soybeans and yellow peas and develops proprietary seed coatings with nitrogen-fixing bacteria adapted to the European climate.
AgTechBiotechFoodTechGent, BE
Benjamin Laga(Co-founder & CEO)inJonas Aper(Co-founder & Director of Breeding)in
Co-investorsAgri Investment FundInnovation IndustriesKorysV-Bio VenturesEstari GroupPMV+1 more
Aneta operates an email-based AI research service that runs 15 specialized agents across academic, market, technical, and legal sources for days to produce long, citation-backed research reports.
AI & Machine LearningEnterprise SoftwareSaaS
Co-investorsPebblebedAndera PartnersBGVForbionFountain Healthcare PartnersHTGF+2 more
Animab develops proprietary antibodies that mimic natural intestinal protection mechanisms to safeguard piglets' health during post-weaning, a critical period in livestock production.
AgTechBiotechDeep TechHealthtechGhent, BE
Vikram Virdi(Chief Science Officer & Scientific Co-Founder)inAnn DepickerNico CallewaertEric CoxHenri De GreveAlain Wille(CEO)in
Co-investorsAgri Investment FundSeventure PartnersPMVQbic FundV-Bio VenturesAIF
Rainbow Crops applies AI, genome engineering, and field validation to help seed and breeding companies develop crops with complex traits such as yield stability and drought, heat, and disease resilience.
AgTechAI & Machine LearningBiotech
Co-investorsAgri Investment FundLIFTTMaia VenturesPINCQbic FundAIF
Portfolio news
latest coverage across their companies
Rainbow Crops · prnewswire.com · Sep 21, 2026
MRM Health · eu-startups.com · Sep 4, 2025
Frequently asked questions
- How many investments has VIB made?
- VIB has 8 tracked investments, including 1 dated in the last 24 months.
- What stage does VIB invest at?
- VIB invests at the Seed, Series A stages.
- What sectors does VIB focus on?
- VIB focuses on AgTech, AI & Machine Learning, Biotech, FoodTech.
- Where is VIB located?
- VIB is headquartered in Ghent, BE.
- Does VIB lead rounds?
- VIB typically participates in rounds rather than leading them.
Media · Podcasts & interviews
from their channelNEW | Episode 14: Lia Martina – From pipettes to policy
VIB
NEW | Episode 12: Ayşe Candayan – Grants, genes, and grit
VIB
NEW | Episode 13: Thomas Jacobs – Transplanting, adapting, and flourishing in a new environment
VIB
NEW | Episode 11: Laurent Galibert – A lifelong mission in drug discovery
VIB
NEW | Episode 15: Inge Van Molle – What it takes to be a jack of all trades
VIB
BioImaging Core Cribs
VIB
Images
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Kibo Ventures is a Spanish venture capital firm that backs startups, having served as an early and long-term institutional investor to companies across Spain and Europe.
Lerer Hippeau is an early-stage venture capital firm that backs founders across sectors, emphasizing investing in companies before they gain wider recognition.
Valor is a private investment firm focused on operational growth, investing in technology and technology-enabled companies that innovate and disrupt existing industries.
Snatched Ventures is a San Francisco-based early-stage venture capital firm backing DeepTech startups focused on sustainable innovation and operational transformation. It is led by a two-GP team combining corporate development and institutional investment management experience.